Page 147 - Functional impairment and cues for rehabilitation of head and neck cancer patients -

25. Wendrich AW, Swartz JE, Bril SI, Wegner I, de Graeff A, Smid EJ, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose- limiting toxicity in patients with locally advanced head and neck cancer. Oral oncology. 2017;71:26-33.
26. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Archives of physical medicine and rehabilitation. 2005;86(8):1516-20.
27. McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17(2):97-114.
28. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral oncology. 2009;45(8):e67-71.
29. Lazarus CL, Husaini H, Hu K, Culliney B, Li Z, Urken M, et al. Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6
months post-treatment. Dysphagia. 2014;29(3):365-75.
30. Boersma P. Praat, a system for doing phonetics by computer. Glot International. 2001;5:9/10:341-5.
31. van Son RJ, Middag C, Demuynck K. Vowel Space as a Tool to Evaluate Articulation Problems. Interspeech. 2018(2018-68):357-61.
32. Rinkel RN, Verdonck-de Leeuw IM, van Reij EJ, Aaronson NK, Leemans CR. Speech Handicap Index in patients with oral and pharyngeal cancer:
better understanding of patients’complaints. Head Neck. 2008;30(7):868-74.
33. Dwivedi RC, St Rose S, Chisholm EJ, Bisase B, Amen F, Nutting CM, et al. Evaluation of speech outcomes using English version of the Speech
Handicap Index in a cohort of head and neck cancer patients. Oral oncology. 2012;48(6):547-53.
34. de Jong NH, Wempe T. Praat script to detect syllable nuclei and measure speech rate automatically. Behav Res Methods. 2009;41(2):385-90.
35. Maryn Y, De Bodt M, Roy N. The Acoustic Voice Quality Index: toward improved treatment outcomes assessment in voice disorders. J Commun
Disord. 2010;43(3):161-74.
36. van Sluis KE, van den Brekel MWM, Hilgers FJM, van Son RJJH. Long-Term Stability of Tracheoesophageal Voices. Proceedings of Interspeech 2016,
San Francisco 2016:102-6.
37. Morley L, Tsang SW, Breen SL, Waldron JN, Maganti M, Pintilie M, et al. Technical challenges of sparing infrahyoid swallowing organs at risk in
oropharynx squamous cell cancer treated with IMRT. Med Dosim. 2014;39(2):146-51.
38. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, et al. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes
after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. The Laryngoscope. 2017;127(4):842-8.
39. Astradsson T, Laurell G, Ahlberg A, Nikolaidis P, Johansson H, Ehrsson YT. Trismus in patients with head and neck cancer and 5-year overall survival.
Acta Otolaryngol. 2018;138(12):1123-7.
40. Karlsson O, Karlsson T, Pauli N, Andrell P, Finizia C. Jaw exercise therapy for the treatment of trismus in head and neck Cancer: a prospective three-
year follow-up study. Support Care Cancer. 2020.
41. Vainshtein JM, Griffith KA, Feng FY, Vineberg KA, Chepeha DB, Eisbruch A. Patient-reported voice and speech outcomes after whole-neck intensity
modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study. International journal of radiation
oncology, biology, physics. 2014;89(5):973-80.
42. Jacobi I, van Rossum MA, van der Molen L, Hilgers FJ, van den Brekel MW. Acoustic analysis of changes in articulation proficiency in patients with
advanced head and neck cancer treated with chemoradiotherapy. Ann Otol Rhinol Laryngol. 2013;122(12):754-62.
43. Chargi N, Bril SI, Swartz JE, Wegner I, Willems SM, de Bree R. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with
oropharyngeal squamous cell carcinoma. Oral oncology. 2020;101:104519.
44. Vangelov B, Kotevski DP, Williams JR, Smee RI. The impact of HPV status on weight loss and feeding tube use in oropharyngeal carcinoma. Oral
oncology. 2018;79:33-9.
45. Vatca M, Lucas JT, Jr., Laudadio J, D’Agostino RB, Waltonen JD, Sullivan CA, et al. Retrospective analysis of the impact of HPV status and smoking
on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Oral oncology.
2014;50(9):869-76.
46. Sharma A, Mendez E, Yueh B, Lohavanichbutr P, Houck J, Doody DR, et al. Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg. 2012;146(5):739-45.
5
Functional outcomes after (C)RT for OPC
145